STAG2 and glioblastoma: A previous study reported absence of STAG2 protein expression in cell lines derived from a range of cancers (glioblastoma, Ewing's sarcoma, melanoma, haematologic, cervical and renal) and identified mutations or homozygous deletion in several of these.